ProShare Advisors’s Edgewise Therapeutics EWTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $248K | Sell |
18,888
-1,315
| -7% | -$17.2K | ﹤0.01% | 1577 |
|
|
2025
Q1 | $444K | Sell |
20,203
-4,725
| -19% | -$104K | ﹤0.01% | 1162 |
|
|
2024
Q4 | $666K | Buy |
24,928
+5,669
| +29% | +$151K | ﹤0.01% | 1108 |
|
|
2024
Q3 | $514K | Buy |
19,259
+5,769
| +43% | +$154K | ﹤0.01% | 1114 |
|
|
2024
Q2 | $243K | Sell |
13,490
-3,395
| -20% | -$61.1K | ﹤0.01% | 1425 |
|
|
2024
Q1 | $308K | Buy |
16,885
+5,748
| +52% | +$105K | ﹤0.01% | 1414 |
|
|
2023
Q4 | $122K | Buy |
+11,137
| New | +$122K | ﹤0.01% | 1753 |
|
|
2023
Q1 | – | Sell |
-10,105
| Closed | -$90.3K | – | 1832 |
|
|
2022
Q4 | $90.3K | Buy |
+10,105
| New | +$90.3K | ﹤0.01% | 1669 |
|
|
2022
Q2 | – | Sell |
-12,378
| Closed | -$120K | – | 1904 |
|
|
2022
Q1 | $120K | Sell |
12,378
-3,015
| -20% | -$29.2K | ﹤0.01% | 1997 |
|
|
2021
Q4 | $235K | Buy |
+15,393
| New | +$235K | ﹤0.01% | 1929 |
|